Maxigen Biotech Inc. (TPE:1783)

Maxigen Biotech Revenue

Maxigen Biotech had revenue of 200.86M TWD in the quarter ending September 30, 2025, with 15.47% growth. This brings the company's revenue in the last twelve months to 792.49M, up 27.05% year-over-year. In the year 2024, Maxigen Biotech had annual revenue of 680.65M with 9.41% growth.

• Revenue (ttm): 792.49M
• Revenue Growth: +27.05%
• P/S Ratio: 4.77
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	680.65M	58.54M	9.41%
Dec 31, 2023	622.12M	17.68M	2.93%
Dec 31, 2022	604.43M	92.46M	18.06%
Dec 31, 2021	511.98M	54.29M	11.86%
Dec 31, 2020	457.69M	5.49M	1.21%